Corton Capital Inc. Relay Therapeutics, Inc. Transaction History
Corton Capital Inc.
- $196 Million
- Q3 2024
A detailed history of Corton Capital Inc. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 29,763 shares of RLAY stock, worth $133,933. This represents 0.11% of its overall portfolio holdings.
Number of Shares
29,763
Previous 20,630
44.27%
Holding current value
$133,933
Previous $134,000
56.72%
% of portfolio
0.11%
Previous 0.07%
Shares
8 transactions
Others Institutions Holding RLAY
# of Institutions
204Shares Held
156MCall Options Held
207KPut Options Held
40K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$126 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$65.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$47.4 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.25MShares$41.6 Million5.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.38MShares$33.2 Million0.88% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $541M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...